Accredited Industry-Supported Symposia: Rethinking the Reconstructive Ladder: Innovation in Autologous Cutaneous Multicellular Therapy for DFU Reconstruction

Learning objectives:
• Assess gaps in the reconstructive ladder for diabetic foot ulcers, including limitations of flaps and grafts on the plantar surface, to improve durable wound closure.
• Evaluate where autologous cutaneous multicellular therapy fits within the reconstructive ladder for diabetic foot ulcers, including its role in bridging gaps between traditional grafting and advanced reconstruction to promote tissue regeneration and wound closure.
• Evaluate the scientific rationale and clinical evidence supporting autologous cutaneous multicellular therapy, including Phase 2 outcomes demonstrating improved wound closure, alongside emerging late-breaking Phase 3 data supporting BLA submission in diabetic foot ulcers.
• Evaluate clinical outcomes associated with autologous cutaneous multicellular therapy through case-based analysis

HMP Education has designated an unrestricted grant from Polarity Bio for this session.

This session will award 1.00 pharmacotherapeutic contact hour.